Loading clinical trials...
Loading clinical trials...
This study will assess the efficacy and safety of secukinumab in patients with active ankylosing spondylitis who are intolerant to or have had an inadequate response to NSAIDs, DMARDs and / or TNFα in...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Novartis Pharmaceuticals
NCT07627542 · Rheumatoid Arthritis (RA), Ankylosing Spondylitis (AS), and more
NCT07536529 · Inflammatory Joint Diseases, Rheumatoid Arthritis (RA), and more
NCT04876781 · Active Moderate to Severe Rheumatoid Arthritis, Active Ankylosing Spondylitis, and more
NCT04402086 · Rheumatic Diseases, Adult Onset Still Disease, and more
NCT04806620 · Post-Acute COVID-19 Syndrome, ME/CFS, and more
Novartis Investigative Site
Boise, Idaho
Novartis Investigative Site
Cedar Rapids, Iowa
Novartis Investigative Site
Portland, Oregon
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions